All stock lists
Mangoceuticals, Inc. (NASDAQ:MGRX)
US · Delayed Price · Currency is USD
0.23-0.01 (-2.55%)
Insider Score
––Not scored
MGRX Insider Score
Insiders here have filed 5 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
MGRX Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 68.76 K | 67.86 K | 94.36 K | 84.25 K | 168.11 K | 109.31 K |
| Revenue Growth (YoY) | -59.10 % | -37.91 % | -10.34 % | -36.83 % | 3.03 % | -48.95 % |
| Cost of Revenue | 24.54 K | 38.86 K | 46.88 K | 33.35 K | 78.16 K | 47.24 K |
| Gross Profit | 44.22 K | 29.00 K | 47.48 K | 50.90 K | 89.95 K | 62.06 K |
| SG&A Expense | 569.99 K | 1.15 M | -4.59 M | 416.29 K | 5.25 M | 3.50 M |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.08 M | 3.16 M | 1.54 M | 7.59 M | 5.36 M | 4.92 M |
| Operating Income | -1.03 M | -3.13 M | -1.49 M | -7.54 M | -5.27 M | -4.85 M |
| Pretax Income | -1.31 M | -3.40 M | -2.77 M | -7.62 M | -5.42 M | -4.84 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -1.31 M | -3.40 M | -2.77 M | -7.62 M | -5.42 M | -4.84 M |
| EPS (Basic) | -0.09 | -0.22 | -0.19 | -0.66 | -0.57 | -1.05 |
| EPS (Diluted) | -0.09 | -0.22 | -0.19 | -0.66 | -0.57 | -1.05 |
| Shares Outstanding | 17.12 M | 16.48 M | 15.89 M | 11.52 M | 9.98 M | 4.59 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.